| 1.966 -0.094 (-4.56%) | 04-25 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 2.46 |
1-year : | 2.76 |
| Resists | First : | 2.11 |
Second : | 2.36 |
| Pivot price | 2.02 |
|||
| Supports | First : | 1.7 | Second : | 1.41 |
| MAs | MA(5) : | 1.99 |
MA(20) : | 2.04 |
| MA(100) : | 1.85  |
MA(250) : | 2.04 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 57.9 |
D(3) : | 56.8 |
| RSI | RSI(14): 46.7 |
|||
| 52-week | High : | 3.74 | Low : | 1.05 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ BEAT ] has closed above bottom band by 37.2%. Bollinger Bands are 42.2% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 2 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 2.07 - 2.09 | 2.09 - 2.09 |
| Low: | 1.92 - 1.93 | 1.93 - 1.94 |
| Close: | 1.95 - 1.97 | 1.97 - 1.98 |
HeartBeam, Inc., a medical technology company, primarily focuses on telemedicine solutions for the detection and monitoring of cardiac disease outside a healthcare facility setting. The company also focuses on providing diagnostic data to physicians with care management of patients with cardiovascular disease. Its telehealth product comprises a credit card sized electrocardiogram machine and a cloud-based diagnostic software system to address the rapidly growing field of remote patient monitoring. The company was incorporated in 2015 and is headquartered in Santa Clara, California.
Thu, 25 Apr 2024
HeartBeam to Host First Quarter 2023 Results Conference Call on Thursday May 9, 2024 at 4:30 p.m. Eastern Time - Business Wire
Tue, 09 Apr 2024
HeartBeam Presents Positive Results on its Artificial Intelligence Capabilities for Detecting Arrhythmias - Business Wire
Thu, 21 Mar 2024
HeartBeam, Inc. (NASDAQ:BEAT) Q4 2023 Earnings Call Transcript - Yahoo Finance
Wed, 20 Mar 2024
HeartBeam Reports Fourth Quarter and Full Year 2023 Financial Results - Business Wire
Wed, 20 Mar 2024
HeartBeam, Inc. (BEAT) Q4 2023 Earnings Call Transcript - Seeking Alpha
Thu, 14 Mar 2024
First Patients Enrolled in Pivotal Study Evaluating HeartBeam's AIMIGo™ System for Synthesizing a 12-Lead ECG - Business Wire
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Healthcare Information Services
|
|
| Shares Out | 26 (M) |
| Shares Float | 19 (M) |
| Held by Insiders | 28.1 (%) |
| Held by Institutions | 8.8 (%) |
| Shares Short | 159 (K) |
| Shares Short P.Month | 38 (K) |
| EPS | -0.73 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0.61 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | -90.5 % |
| Return on Equity (ttm) | -159.9 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -12 (M) |
| Levered Free Cash Flow | -7 (M) |
| PE Ratio | -2.74 |
| PEG Ratio | 0 |
| Price to Book value | 3.22 |
| Price to Sales | 0 |
| Price to Cash Flow | -4.29 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|